NOVARTIS INC 2024-18.06.31 REG SNOVARTIS INC 2024-18.06.31 REG SNOVARTIS INC 2024-18.06.31 REG S

NOVARTIS INC 2024-18.06.31 REG S

No trades
See on Supercharts

A3LZ2R analysis



Key facts


Issue date
Jun 18, 2024
Maturity date
Jun 18, 2031
Outstanding amount
‪435.00 M‬CHF
Face value
5,000.00CHF
Minimum denomination
5,000.00CHF
Coupon
1.65% (Fixed)
Yield to maturity
0.87%
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.